These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8505810)

  • 41. [Eosinophilic myalgia from L-tryptophan].
    Hardelin D; Saviuc P; Mallaret M; Brousse P; Danel V
    J Toxicol Clin Exp; 1990 Oct; 10(6):409-12. PubMed ID: 2130184
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.
    Freimer ML; Glass JD; Chaudhry V; Tyor WR; Cornblath DR; Griffin JW; Kuncl RW
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):352-8. PubMed ID: 1534836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current aspects in discussion of eosinophilia-myalgia syndrome].
    Zipp F; Demisch L
    Nervenarzt; 1992 Apr; 63(4):249-53. PubMed ID: 1594093
    [No Abstract]   [Full Text] [Related]  

  • 44. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
    Mizutani T; Mizutani H; Hashimoto K; Nakamura Y; Kishida M; Taniguchi H; Murata M; Kuzuhara S; Shimizu M
    J Am Acad Dermatol; 1991 Sep; 25(3):512-7. PubMed ID: 1918490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
    Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
    Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
    Tanhehco JL; Wiechers DO; Golbus J; Neely SE
    Muscle Nerve; 1992 May; 15(5):561-7. PubMed ID: 1584247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan.
    Greenberg AS; Takagi H; Hill RH; Hasan A; Murata H; Falanga V
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):264-6. PubMed ID: 8708033
    [No Abstract]   [Full Text] [Related]  

  • 48. Tryptophan induced eosinophilia-myalgia syndrome: clinical and microscopic findings.
    Groves RW; Simpson KJ; Koblar S; Pitzalis C; Hay RJ
    J R Soc Med; 1992 Feb; 85(2):111-2. PubMed ID: 1538375
    [No Abstract]   [Full Text] [Related]  

  • 49. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
    de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
    Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eosinophilia-myalgia syndrome in a child with phenylketonuria.
    Springer MA; Bock HG; Philen RM; Hill RH; Crawford LV
    Pediatrics; 1992 Oct; 90(4):630-3. PubMed ID: 1408523
    [No Abstract]   [Full Text] [Related]  

  • 51. Central and peripheral nervous system involvement in the L-tryptophan associated eosinophilia myalgia syndrome.
    Tolander LM; Bamford CR
    Int J Neurosci; 1991 Nov; 61(1-2):69-75. PubMed ID: 1809736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
    Daniels SR; Hudson JI; Horwitz RI
    J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Eosinophilia-myalgia: new syndrome].
    Szechiński J; Borysewicz K
    Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale.
    Mayeno AN; Gleich GJ
    Trends Biotechnol; 1994 Sep; 12(9):346-52. PubMed ID: 7765187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].
    Grangeia Tde A; Schweller M; Paschoal IA; Zambon L; Pereira MC
    J Bras Pneumol; 2007; 33(6):747-51. PubMed ID: 18200378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Muscle pain, scleroderma-like skin changes and eosinophilia following administration of a psychotropic drug].
    Scheurlen C; Neubrand M; Fischer G; Soehnchen R; Kröner G; Sauerbruch T
    Internist (Berl); 1992 Apr; 33(4):269-73. PubMed ID: 1612852
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acute pleuropericarditis with eosinophilia after ingestion of tryptophan].
    Dell'Isola B; Rezgui N; Thiollieres JM; Labrousse J; Lissac J; Valcke JC
    Rev Med Interne; 1993 May; 14(5):353-4. PubMed ID: 8235154
    [No Abstract]   [Full Text] [Related]  

  • 59. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
    Hertzman PA
    Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents.
    Priori R; Conti F; Luan FL; Arpino C; Valesini G
    Eur J Pediatr; 1994 May; 153(5):344-6. PubMed ID: 8033924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.